Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers Results available

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

ClinicalTrials.gov ID: NCT06151288

Public ClinicalTrials.gov record NCT06151288. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Randomized, Observer-Blind, Dose-Finding, Active-Controlled, Parallel-Group, Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Healthy Adults Aged 50 Years and Older

Study identification

NCT ID
NCT06151288
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Vaxcyte, Inc.
Industry
Enrollment
1,015 participants

Conditions and interventions

Interventions

  • 31 valent pneumococcal conjugate vaccine Biological
  • 20 valent pneumococcal conjugate vaccine Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 7, 2023
Primary completion
Jul 16, 2024
Completion
Jul 16, 2024
Last update posted
Jul 27, 2025

2023 – 2024

United States locations

U.S. sites
25
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
AMR Mobile Mobile Alabama 36608
AMR Phoenix Phoenix Arizona 85282
Research Centers of America Hollywood Florida 33024
Health Awareness Jupiter Florida 33458
Optimal Research Melbourne Florida 32934
Precision Clinical Research Sunrise Florida 33351
Velocity Clinical Research, Savannah Savannah Georgia 31406
Healthcare Research Network II, LLC Flossmoor Illinois 60422
Johnson County Clin-Trials Lenexa Kansas 66219
DM Clinical Research - Detroit Detroit Michigan 48076
Velocity Clinical Research Omaha Omaha Nebraska 68134
WR-CRCN Las Vegas Nevada 89106
Cenexel AMRI Toms River New Jersey 08755
Rochester Clinical Research Rochester New York 14609
CTI Clinical Research Center Cincinnati Ohio 45212
Velocity Clinical Research, Cleveland Cleveland Ohio 44122
DM Clinical Research - Philadelphia Philadelphia Pennsylvania 19107
Velocity Clinical Research Warwick Rhode Island 02886
Coastal Carolina Research North Charleston South Carolina 29405
AMR Knoxville Knoxville Tennessee 37909
Benchmark Research Fort Worth Texas 76135
Benchmark Research San Angelo Texas 76904
CenExel JBR Clinical Research Salt Lake City Utah 84107
Charlottesville Medical Research Charlottesville Virginia 22911
Health Research of Hampton Roads Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06151288, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06151288 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →